Hormone replacement therapy
1 Davis, P. 2008. Use of oral contraceptives and postmenopausal hormone
replacement: Evidence on risk of stroke. Curr. Treat. Options Neurol., 10
(6), 468–74. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18990315 (accessed
02.23.2009).
Shapiro, S. 2008. Oral contraceptives, hormone therapy and cardiovascular
risk. Climacteric, 11 (5), 355–363. URL: (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18781479
(accessed 02.23.2009).
Grodstein, F., et al. 2008. Postmenopausal hormone therapy and stroke:
Role of time since menopause and age at initiation of hormone therapy. Arch. Intern.
Med., 168 (8), 861–866. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18443262
(accessed 02.23.2009).
2 Hedrick, R., et al. 2009. Transdermal estradiol gel 0.1% for the treatment
of vasomotor symptoms in postmenopausal women. Menopause, 16 (1), 132–140.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18971794 (accessed 02.06.2009).
3 Sites, C. 2008. Bioidentical hormones for menopausal therapy, p. 8:
Use of bioidentical progesterone. URL: http://www.medscape.com/viewarticle/571299_8
(accessed 02.09.2009).
Return to:
Bioidentical hormone replacement therapy — a guide
to your options and alternatives
Last Modified Date: 04/29/2011